Skinbiotherapeutics is there a placing underway – response from Stuart Ashman
By Tom Winnifrith | Wednesday 15 November 2023
Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
I have been involved with the stockmarket for 33 years. I have done almost every job going: analyst, CEO, fund manager – crap one - even, don’t laugh, compliance officer so I get really fucked off when folks lecture me about what the rules are, especially when they clearly don’t know them themselves. I really do not like being patronized and that brings me to Stuart Ashman and Skinbiotherapeutics (SBTX) where I am, of course, a loyal shareholder.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism
Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.